These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3609118)

  • 21. [Pharmacokinetic and clinical research on a new antibiotic combination (amoxicillin and flucloxacillin in equivalent-weight dose)].
    Di Nola F; Soranzo ML; Bosio G; Sachelariu N; Mastroviti S
    Minerva Med; 1977 Mar; 68(14):917-28. PubMed ID: 321992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pacemaker infections. A clinical study with special reference to prophylactic use of some isoxazolyl penicillins.
    Bluhm G
    Acta Med Scand Suppl; 1985; 699():1-62. PubMed ID: 3904338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The penetration of flucloxacillin into cortical and cancellous bone during arthroplasty of the knee.
    Holm S; Larsson SE
    Int Orthop; 1982; 6(4):243-7. PubMed ID: 7183576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flucloxacillin in bone.
    Unsworth PF; Heatley FW; Phillips I
    J Clin Pathol; 1978 Aug; 31(8):705-11. PubMed ID: 690233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concentrations of flucloxacillin in heart valves and subcutaneous and muscle tissues of patients undergoing open-heart surgery.
    Frank U; Schmidt-Eisenlohr E; Schlosser V; Spillner G; Schindler M; Daschner FD
    Antimicrob Agents Chemother; 1988 Jun; 32(6):930-1. PubMed ID: 3415213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flucloxacillin in chronic leg ulcers. Penetration of flucloxacillin into chronic leg ulcer exudate and the effect on the bacteria.
    Stürup J; Sandberg Sørensen T; Slotsbjerg T; Hofmann B
    Acta Pathol Microbiol Immunol Scand B; 1987 Aug; 95(4):213-7. PubMed ID: 3673578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dicloxacillin and flucloxacillin: pharmacokinetics, protein binding and serum bactericidal titers in healthy subjects after oral administration.
    Røder BL; Frimodt-Møller N; Espersen F; Rasmussen SN
    Infection; 1995; 23(2):107-12. PubMed ID: 7622258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Flucloxacillin].
    Mastroviti S; Cassarino G
    G Batteriol Virol Immunol; 1975; 68(7-12):279-88. PubMed ID: 1234594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bactericidal activity and pharmacology of flucloxacillin.
    Bergeron MG; Brusch JL; Barza M; Weinstein L
    Am J Med Sci; 1976; 271(1):13-20. PubMed ID: 3969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flucloxacillin, a new isoxazolyl penicillin, compared with oxacillin, cloxacillin, and dicloxacillin.
    Sutherland R; Croydon EA; Rolinson GN
    Br Med J; 1970 Nov; 4(5733):455-60. PubMed ID: 5481218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flucloxacillin in the treatment of infectious conditions in children.
    Price JD; Harding JW
    Curr Med Res Opin; 1975; 3(2):77-82. PubMed ID: 1139964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to calculate clearance of highly protein-bound drugs during continuous venovenous hemofiltration demonstrated with flucloxacillin.
    Meyer B; Ahmed el Gendy S; Delle Karth G; Locker GJ; Heinz G; Jaeger W; Thalhammer F
    Kidney Blood Press Res; 2003; 26(2):135-40. PubMed ID: 12771540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetic modelling of total and unbound flucloxacillin in non-critically ill patients to devise a rational continuous dosing regimen.
    Wilkes S; van Berlo I; Ten Oever J; Jansman F; Ter Heine R
    Int J Antimicrob Agents; 2019 Mar; 53(3):310-317. PubMed ID: 30472288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigations on the flucloxacillin levels in human serum, lung tissue, pericardial fluid and heart tissue.
    Kiss IJ; Faragó E; Gömöry A; Szamaránszky J
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):405-11. PubMed ID: 7450932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome.
    Frey FJ; Frey BM
    Am J Kidney Dis; 1984 Mar; 3(5):339-48. PubMed ID: 6702820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The simplified oral flucloxacillin absorption test: an accurate method to identify patients with inadequate oral flucloxacillin absorption.
    Dijkmans AC; Kweekel DM; Balmforth C; van Esdonk MJ; van Dissel JT; Burggraaf J; Kamerling IMC
    Neth J Med; 2019 Sep; 77(7):255-260. PubMed ID: 31582580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flucloxacillin kinetics in newborn infants.
    Thijssen HH
    Eur J Clin Pharmacol; 1988; 35(1):114. PubMed ID: 3220094
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetics of flucloxacillin and its metabolites in patients with renal failure: Impact on liver toxicity
.
    Maier-Salamon A; Elgendy SA; Meyer B; Vossen M; Thalhammer T; Thalhammer F; Jäger W
    Int J Clin Pharmacol Ther; 2017 Sep; 55(9):701-711. PubMed ID: 28737131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total flucloxacillin plasma concentrations poorly reflect unbound concentrations in hospitalized patients with Staphylococcus aureus bacteraemia.
    Chin PKL; Drennan PG; Gardiner SJ; Zhang M; Dalton SC; Chambers ST; Begg EJ
    Br J Clin Pharmacol; 2018 Oct; 84(10):2311-2316. PubMed ID: 29908071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of oral and intravenous indomethacin in preterm infants.
    Bhat R; Vidyasagar D; Fisher E; Hastreiter A; Ramirez JL; Burns L; Evans M
    Dev Pharmacol Ther; 1980; 1(2-3):101-10. PubMed ID: 6927543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.